📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-21 12:39
453 analysed today
453
Today
133,342
All-time analysed
40,106
Positive
6,279
Negative
79,144
Neutral
7,745
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
18 announcements match the current filters (relevance ≥ 5).
High Court Quashes ₹8.48 Cr GST Demand; IGCL to Receive ~₹8.11 Cr Tax Refund
The Hon'ble High Court of Punjab and Haryana has ruled in favor of Indogulf Cropsciences Limited, quashing a GST show cause notice and order-in-original demanding recovery of ₹6,93,12,901 along with interest of ₹1,54,58,004 (total ~₹8.48 crore). The dispute pertained to an alleged erroneous IGST refund under Rule 96(10). Following this order, the company's prior voluntary deposit of ₹6,56,07,859 (IGST) and ₹1,54,58,004 (interest)—totaling ~₹8.11 crore—will be refunded back to IGCL in due course.
Confidence: HIGH
What changedHigh Court set aside the ₹8.48 crore tax & interest demand, enabling IGCL to recover ~₹8.11 crore in pre-deposited funds.
Why it mattersEliminates tax litigation risk and provides a liquidity boost of ~₹8.11 crore (equivalent to ~3.6% of FY26 TTM PAT).
Quashed tax demand: ₹6,93,12,901Quashed interest demand: ₹1,54,58,004Refundable voluntary deposit: ₹8,10,65,863Refund as % of TTM PAT: ~3.6%
📅 Short termProvides positive sentiment by resolving tax ambiguity and confirming upcoming cash recovery.
📈 Long termLimited structural impact on the ongoing core agrochemicals business.
⚠ Risk flags
- Potential appeal or review petition by the GST department in higher judicial forums
Key Highlights
Punjab & Haryana High Court quashed tax demand of ₹6,93,12,901 and interest of ₹1,54,58,004.
IGCL to receive a refund of ₹8,10,65,863 (₹6.56 cr IGST + ₹1.55 cr interest) previously deposited voluntarily.
Allegation by Central GST Commissionerate Rohtak concerned Rule 96(10) IGST refund recovery.
Final order dated August 14, 2026 was received by the company on August 20, 2026.
👀 What to Watch
Track the timeline of the actual cash inflow from the tax refund and its recognition in subsequent quarterly financials.
IGCL Q1 FY27: Revenue declines 11% to ₹168.5 Cr; Gross Margins expand to 28%
Indogulf Cropsciences (IGCL) reported a challenging Q1 FY27 with revenue declining 11% YoY to ₹168.5 crore, primarily due to erratic monsoon patterns impacting sales volumes. Despite the top-line contraction, the company achieved a significant gross margin expansion to 28.0% from 22.0% in Q1 FY26, driven by a shift toward differentiated products. However, Net Profit (PAT) fell 38% YoY to ₹2.4 crore, weighed down by higher operating expenses and finance costs. The company remains focused on its 50% capacity expansion at the Sonipat plant, which is slated for completion by Q1 FY2027.
Confidence: HIGH
What changedThe company experienced a double-digit decline in both revenue and net profit for Q1 FY27, although it successfully improved its gross margin profile.
Why it mattersThe results highlight the company's vulnerability to monsoon patterns while demonstrating a strategic shift toward higher-margin, differentiated agrochemical products to protect profitability.
Q1 FY27 Revenue: ₹168.5 crYoY Revenue Growth: -11%Gross Margin: 28.0%Q1 FY27 PAT: ₹2.4 crPlanned Capacity Expansion: 50%
📅 Short termThe stock may face pressure due to the significant decline in quarterly profits and revenue, reflecting immediate operational headwinds from the monsoon.
📈 Long termThe structural story depends on the successful commissioning of the Sonipat expansion by FY2027 and the ability to scale the B2C and export segments.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Erratic monsoon patterns impacting demand
- 25-30% dependency on raw material imports
- Regulatory risks from potential pesticide bans
Key Highlights
Revenue from operations fell 11% YoY to ₹168.5 crore in Q1 FY27 from ₹189.4 crore.
Gross Profit margin improved by 600 basis points YoY to 28.0% through better product mix.
Profit After Tax (PAT) decreased 38% YoY to ₹2.4 crore compared to ₹3.9 crore in the previous year.
B2C segment contributed 47% of total revenue, while B2B and Exports accounted for 31% and 13% respectively.
Planned 50% capacity expansion at the Sonipat plant is on track for completion by Q1 FY2027.
👀 What to Watch
Monitor the execution timeline of the Sonipat plant expansion and the recovery of sales volumes in the upcoming quarters, as Q1 was heavily impacted by weather conditions. Watch for the growth in the 'Biologicals' segment, which currently contributes only 3% to revenue but is a high-margin focus area.
₹1,685 Mn Revenue in Q1 FY27: IGCL Reports 12% QoQ Growth but 38% YoY PAT Decline
Indogulf Cropsciences (IGCL) reported a sequential revenue recovery of 12% to ₹168.5 cr in Q1 FY27, although revenue declined 11% on a year-on-year basis. Profit After Tax (PAT) saw a sharp contraction of 38% YoY, falling to ₹2.4 cr, with net margins thinning to just 1%. A positive operational highlight is the increase in manufacturing capacity utilization to 70%, up from 52% in FY26. The company is currently focusing on its Barwasni facility expansion and diversifying into biologicals to mitigate macro headwinds.
Confidence: HIGH
What changedIGCL has reported its first quarter results for FY27, showing a recovery in sales volume compared to the previous quarter but a significant decline in profitability compared to the same period last year.
Why it mattersThe results indicate that while the company is successfully utilizing more of its capacity (70%), it is struggling to convert that into bottom-line growth, with net profit margins remaining extremely low at 1%.
Revenue (Q1 FY27): ₹1,685 millionPAT (Q1 FY27): ₹24 millionCapacity Utilization: 70%YoY PAT Growth: -38%Q1 Revenue vs FY26 Revenue: 6.18%
📅 Short termThe stock may face downward pressure in the short term due to the substantial 38% YoY decline in net profit and the sequential drop in EBITDA margins from 14% to 6%.
📈 Long termLong-term value depends on the company's ability to scale its biologicals portfolio and successfully complete the Barwasni expansion to achieve economies of scale.
⚠ Risk flags
- Low net profit margin (1%)
- Significant YoY earnings contraction
- High dependency on seasonal monsoon patterns
Key Highlights
Revenue from operations stood at ₹1,685 million, reflecting a 12% sequential growth but an 11% YoY decline.
Profit After Tax (PAT) decreased by 38% YoY to ₹24 million from ₹39 million in the year-ago quarter.
Manufacturing capacity utilization improved significantly to 70% in Q1 FY27 compared to 52% for the full year FY26.
Gross profit grew 12% YoY to ₹466 million, with gross margins improving to 28% due to better product mix.
EBITDA margins stood at 6%, a slight improvement of 47 bps YoY, but a sharp drop from 14% in Q4 FY26.
👀 What to Watch
Investors should monitor the execution timeline of the Barwasni facility expansion and whether the improved capacity utilization (70%) leads to better operating leverage in the high-growth Q2 period. The significant gap between gross margins (28%) and net margins (1%) warrants a close watch on rising operational and branding expenses.
IGCL Q1 FY27 Results: Consolidated Revenue at ₹168.5 Cr, PAT down 37.6% YoY to ₹2.4 Cr
Indogulf Cropsciences Limited (IGCL) reported a consolidated revenue of ₹168.54 cr for Q1 FY27, representing an 11% decline from ₹189.37 cr in the same quarter last year. Net profit (PAT) fell significantly by 37.6% YoY to ₹2.41 cr, down from ₹3.87 cr. The company faced severe margin pressure, with total expenses accounting for 98.6% of operational revenue, resulting in a thin Profit Before Tax (PBT) margin of 1.85%. These results highlight the extreme seasonality of the business, where Q1 typically contributes a small fraction of annual revenue.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results, showing a contraction in both revenue and profitability compared to the previous year's corresponding quarter.
Why it mattersThe results underscore the company's high operational costs and vulnerability to seasonal fluctuations in the agrochemical sector, with current margins leaving little room for error.
Revenue (Q1 FY27): ₹168.54 crPAT (Q1 FY27): ₹2.41 crYoY Revenue Growth: -11.0%PBT Margin: 1.85%Q1 Revenue vs FY26 Revenue: ~6.2%
📅 Short termThe stock is likely to face negative sentiment in the short term due to the sharp YoY decline in PAT and very thin operating margins.
📈 Long termLong-term prospects depend on the successful commissioning of the Sonipat expansion by FY2027 and reducing dependency on imported raw materials (currently 25-30%).
⚠ Risk flags
- High operational expenses (98.6% of revenue)
- Extreme seasonality (Q1 is a minor contributor to annual totals)
- Raw material import dependency
Key Highlights
Consolidated Revenue from operations decreased 11% YoY to ₹168.54 cr from ₹189.37 cr.
Consolidated Net Profit (PAT) dropped 37.6% YoY to ₹2.41 cr compared to ₹3.87 cr in Q1 FY26.
Total expenses for the quarter stood at ₹166.27 cr, nearly matching the total income of ₹169.43 cr.
Basic Earnings Per Share (EPS) for the quarter declined to ₹0.38 from ₹0.80 in the year-ago period.
Finance costs for the quarter were ₹4.51 cr, impacting the bottom line.
👀 What to Watch
Investors should monitor the execution of the 50% capacity expansion at the Sonipat plant, which is critical for scaling beyond the current seasonal peaks, and track the revenue contribution from the 12 new products launched in H1 FY26.
Indogulf Cropsciences Reports 19% Revenue Growth in FY26; Q4 PAT Rises to INR 12 Crore
Indogulf Cropsciences Limited (IGCL) delivered a resilient performance in FY26, reporting a 19% YoY revenue growth to INR 705 crores. For Q4 FY26, revenue stood at INR 151 crores, up 19% YoY, while PAT also grew 19% to INR 12 crores. However, EBITDA margins for the quarter contracted to 13.5% from 16.5% due to higher employee expenses and volatile input costs. The company is actively expanding its global footprint, recently executing its first shipment to Venezuela and entering markets like Taiwan and Sri Lanka.
Key Highlights
Full-year FY26 revenue grew by 19% YoY to INR 705 crores despite industry-wide challenges like inventory normalization.
Q4 FY26 PAT increased by 19% YoY to INR 12 crores, though EBITDA margins dipped to 13.5% due to rising operating costs.
Overall manufacturing capacity utilization improved to approximately 52% during the fiscal year.
Successfully expanded export operations to Venezuela, Taiwan, and Africa, diversifying geographical risk.
The company is scaling its subsidiary, AbhiPrakash Globus Private Limited (AGPL), to deepen rural market penetration.
👀 What to Watch
Investors should monitor the company's margin recovery in upcoming quarters as it navigates raw material volatility and potential El Nino impacts. The shift toward high-margin biologicals and expanded export reach are positive long-term value drivers.
IGCL FY26 Net Profit Rises 19.7% to ₹386.12 Million; New Auditors Appointed
Indogulf Cropsciences Limited (IGCL) reported a steady growth in its financial performance for the fiscal year ended March 31, 2026. Annual revenue from operations increased by 8% to ₹5,966.76 million compared to ₹5,521.84 million in the previous year. Net profit for the full year saw a significant jump of 19.7%, reaching ₹386.12 million. Additionally, the board approved the appointment of new Secretarial, Cost, and Internal Auditors for the upcoming fiscal year to strengthen corporate governance.
Key Highlights
Annual Revenue from operations grew 8% YoY to ₹5,966.76 million in FY26
Full-year Net Profit increased to ₹386.12 million from ₹322.40 million in FY25
Q4 FY26 standalone revenue stood at ₹1,229.18 million with a net profit of ₹120.97 million
Board recommended M/s NJ & Associates as Secretarial Auditors for a 5-year term starting FY27
Internal and Cost Auditors appointed for FY27 to enhance compliance and audit oversight
👀 What to Watch
Investors should view the double-digit profit growth and the strengthening of the audit framework as positive indicators of corporate health. The stock remains a watch for sector-specific growth in agro-chemicals.
Indogulf Cropsciences Reports FY26 Growth: 12 New Launches and Expansion to 34+ Countries
Indogulf Cropsciences Limited (IGCL) presented its FY26 performance, highlighting a robust portfolio of 300+ products and a presence in over 34 countries. The company reported a steady increase in manufacturing capacity utilization to 52% in FY26, up from 44% in FY23, across its four facilities. With 189 total registrations and 6 patents, IGCL is aggressively expanding its global footprint, including a strategic entry into the Latin American market with its first shipment to Venezuela.
Key Highlights
Successfully launched 12 new products in FY26 and secured a total of 6 patents for innovative agri-solutions.
Expanded global reach to 34+ countries with 189 registrations and 140+ active overseas business partners.
Manufacturing capacity utilization improved to 52% in FY26, supported by four facilities including a large-scale unit at Barwasni.
Revenue mix for FY26 dominated by Crop Protection (85%), followed by Biologicals (6%) and Plant Nutrients (5%).
Strategic focus on high-growth markets like Brazil and Africa, alongside backward integration to reduce dependency on external sourcing.
👀 What to Watch
Investors should track the company's progress in scaling its high-margin Biologicals segment and the successful ramp-up of the Barwasni facility. The increasing number of global registrations and backward integration efforts suggest a strong competitive position for long-term export growth.
IGCL FY26 PAT Jumps 27% to ₹400 Mn; Revenue Grows 19% on Export Expansion
Indogulf Cropsciences Limited (IGCL) reported a strong financial performance for FY26, with consolidated revenue rising 19% YoY to ₹7,046 million. Net profit (PAT) grew significantly by 27% to ₹400 million, supported by a diversified product portfolio and deeper market penetration. While annual EBITDA margins saw a slight contraction of 40bps to 10.4%, the company successfully expanded its export footprint into Venezuela, Taiwan, and Sudan. The company is currently scaling its manufacturing capacity at the Barwasni facility to support future growth.
Key Highlights
Full-year FY26 Revenue from Operations increased 19% YoY to ₹7,046 million.
Profit After Tax (PAT) for FY26 surged 27% YoY to ₹400 million from ₹315 million.
Successfully entered the Latin American market with the first fertilizer shipment to Venezuela.
Distribution network strengthened to over 7,000 distributors and 192 active institutional partners.
Q4 FY26 Revenue grew 19% YoY to ₹1,508 million, though Q4 EBITDA margins contracted by 300bps to 14%.
👀 What to Watch
Investors should focus on the company's ability to maintain its high double-digit PAT growth and monitor the margin recovery in the upcoming quarters. The expansion into Latin American markets and R&D collaborations suggest a strong long-term growth trajectory in the agrochemical space.
IGCL FY26 Net Profit Grows 19.8% to ₹386.12 Million; Q4 Revenue Up 10.2% YoY
Indogulf Cropsciences Limited (IGCL) reported a steady financial performance for the year ended March 31, 2026, with annual revenue reaching ₹5,966.76 million, an 8.4% increase over the previous year. Full-year net profit rose significantly by 19.8% to ₹386.12 million, resulting in an EPS of ₹12.00. However, Q4 FY26 net profit saw a year-on-year decline to ₹96.98 million from ₹127.69 million, despite a 10.2% growth in quarterly revenue. The board also streamlined governance by appointing new internal, cost, and secretarial auditors for the upcoming fiscal year.
Key Highlights
Annual Revenue from operations increased to ₹5,966.76 million in FY26 from ₹5,502.45 million in FY25.
Full-year Net Profit (PAT) grew by 19.8% YoY to ₹386.12 million.
Q4 FY26 Revenue stood at ₹1,354.98 million, up 10.2% compared to ₹1,229.18 million in Q4 FY25.
Earnings Per Share (EPS) for the full year improved to ₹12.00 from ₹10.02 in the previous year.
Board approved the appointment of M/s NJ & Associates as Secretarial Auditors for a 5-year term starting FY 2026-27.
👀 What to Watch
Investors should view the strong annual profit growth as a positive sign of operational efficiency, though the dip in Q4 margins suggests monitoring rising input or operational costs in the near term.
Indogulf Cropsciences Reports Full Compliance in FY26 Annual Secretarial Audit
Indogulf Cropsciences Limited (IGCL) has released its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The audit, conducted by NJ & Associates, confirms that the company has adhered to all applicable SEBI regulations and circulars without any deviations. This marks a significant milestone as it is the company's first full-year compliance report following its listing on July 3, 2025. The report highlights clean records regarding insider trading, board evaluations, and related party transactions.
Key Highlights
Zero deviations or non-compliances reported for the financial year ended March 31, 2026.
The company maintained full compliance with SEBI LODR, ICDR, SAST, and Insider Trading regulations.
No penalties or adverse actions were taken by SEBI or Stock Exchanges during the review period.
Confirmed that no directors are disqualified under Section 164 of the Companies Act, 2013.
First annual secretarial report post-listing on July 3, 2025, demonstrating strong initial governance.
👀 What to Watch
Investors can take confidence in the company's adherence to regulatory frameworks and corporate governance standards. No specific action is required as the report indicates a clean bill of health regarding secretarial and legal compliances.
Indogulf Cropsciences Shareholders Approve Key Director Re-appointments with 99.98% Majority
Indogulf Cropsciences Limited (IGCL) has announced the successful passage of four key resolutions via postal ballot. Shareholders overwhelmingly approved the re-appointment of Mr. Om Prakash Aggarwal as Executive Chairman and Mr. Sanjay Aggarwal as Managing Director, both with 99.98% of valid votes. Additionally, two Independent Directors were re-appointed with similar margins. The high voter turnout, representing approximately 75.94% of the total paid-up capital, reflects strong shareholder confidence in the current leadership.
Key Highlights
Re-appointment of Om Prakash Aggarwal as Executive Chairman approved with 99.98% of valid votes.
Sanjay Aggarwal re-appointed as Managing Director with 99.98% shareholder approval.
Total voter turnout represented approximately 75.94% of the company's total paid-up capital of 6,32,23,997 shares.
Two Independent Directors, Rahul Gupta and Sandeep Bhutani, were also re-appointed with 99.98% majority.
👀 What to Watch
Investors should view this as a sign of management stability and strong shareholder backing. The continuity in leadership is a positive signal for the company's long-term strategic execution.
Indogulf Cropsciences Proposes 5-Year Re-appointment for Chairman and MD
Indogulf Cropsciences Limited (IGCL) has issued a postal ballot notice to seek shareholder approval for the re-appointment of its top leadership for five-year terms. The company proposes extending the tenures of Executive Chairman Om Prakash Aggarwal and Managing Director Sanjay Aggarwal starting April 1, 2026. Additionally, two Independent Directors, Rahul Gupta and Sandeep Bhutani, are proposed for their second five-year terms. Shareholders can cast their votes via e-voting between February 27 and March 28, 2026.
Key Highlights
Proposed 5-year re-appointment of Om Prakash Aggarwal as Executive Chairman starting April 1, 2026.
Proposed 5-year re-appointment of Sanjay Aggarwal as Managing Director starting April 1, 2026.
Re-appointment of Independent Directors Rahul Gupta and Sandeep Bhutani for second 5-year terms.
E-voting period scheduled from February 27, 2026, to March 28, 2026.
Cut-off date for voting eligibility established as February 20, 2026.
👀 What to Watch
Investors should support these resolutions to ensure management continuity and stability in leadership. Monitor the voting results to confirm the formalization of these appointments.
Indogulf Cropsciences Q3 FY26 Revenue Up 17% YoY; 9M PAT Grows 31% to ₹28 Cr
Indogulf Cropsciences reported a resilient Q3 FY26 with revenue growing 17% YoY to INR 116.1 crore, despite a challenging operating environment and subdued crop prices. For the 9M FY26 period, the company achieved a robust 31% growth in PAT to INR 28 crore, driven by strong performance in the B2B segment (up 26%) and plant nutrition (up 23%). The subsidiary AGPL contributed INR 54 crore in sales during the first nine months, showing successful integration and market acceptance. Management highlighted new export orders from Venezuela, Taiwan, and Sudan worth INR 4-5 crore, expected to boost Q4 performance.
Key Highlights
Q3 FY26 Revenue increased 17% YoY to INR 116.1 crore, while EBITDA rose 16% to INR 11.7 crore.
9M FY26 PAT grew by 31% YoY to INR 28 crore, supported by a 19.3% increase in total revenue to INR 553 crore.
B2B segment outperformed with 26% YoY growth, while the Plant Nutrition vertical grew by 23% in the 9M period.
Subsidiary AGPL achieved gross sales of INR 54 crore in 9M FY26, contributing significantly to overall margins.
Secured initial export orders worth INR 4-5 crore from new markets including Venezuela, Taiwan, and Sudan for Q4 execution.
👀 What to Watch
Investors should monitor the scaling of the high-margin Plant Nutrition and Biologicals segments, which are currently outperforming traditional crop protection. The successful expansion into international markets and the steady growth of the AGPL subsidiary provide strong catalysts for future growth.
IGCL Q3FY26 Results: Revenue Up 17% YoY to ₹1,161 Mn, 9M PAT Grows 31%
Indogulf Cropsciences (IGCL) reported a resilient Q3FY26 with revenue growing 17% YoY to ₹1,161 Mn and EBITDA rising 16.4% to ₹117 Mn. While Profit Before Tax (PBT) surged 60.2% to ₹74 Mn, Profit After Tax (PAT) saw a more modest growth of 5.6% YoY at ₹39 Mn for the quarter. The nine-month (9M) performance remains robust, with PAT increasing 31.1% YoY to ₹284 Mn. The company also announced a strategic entry into the Venezuela market, with initial orders expected to be executed in Q4 FY26.
Key Highlights
Q3 Revenue from operations increased 17% YoY to ₹1,161 Mn.
9M FY26 Profit After Tax (PAT) grew significantly by 31.1% YoY to ₹284 Mn.
Profit Before Tax (PBT) for Q3 surged 60.2% YoY to ₹74 Mn from ₹46 Mn.
EBITDA for 9M FY26 increased 23.5% YoY to ₹536 Mn, indicating improved operational efficiency.
Entered the Venezuela market with initial orders slated for execution in the upcoming quarter (Q4 FY26).
👀 What to Watch
Investors should note the strong 9-month growth trajectory and the company's expansion into South American markets. Monitor the Q4 execution of Venezuela orders and the impact of domestic monsoon recovery on the agrochemical segment.
Indogulf Cropsciences Q3 FY26 Revenue Up 17% YoY to ₹116 Cr; PBT Surges 60%
Indogulf Cropsciences reported a resilient Q3 FY26 with revenue growing 17% YoY to ₹1,161 million, driven by strong performance in B2B and B2C segments. Despite a challenging environment with subdued crop prices, the company achieved a 60% YoY growth in PBT to ₹74 million. For the 9M FY26 period, revenue and EBITDA grew by 19% and 23% respectively, supported by a 21% revenue contribution from new product launches. The company is expanding its global footprint, recently entering Venezuela and Taiwan, and is utilizing IPO proceeds for debt reduction and a new dry flowable plant.
Key Highlights
Q3 FY26 revenue increased 17% YoY to ₹1,161 million, while 9M FY26 revenue rose 19% to ₹5,538 million.
PBT for Q3 FY26 saw a significant jump of 60% YoY to ₹74 million, reflecting improved operational efficiencies.
New products launched in the last 3 years contributed 21% to the 9M FY26 revenue, highlighting R&D success.
International expansion continues with 34+ countries reached and new market entries in Venezuela and Taiwan.
Utilization of ₹1,600 million IPO proceeds is underway for debt reduction and setting up a new dry flowable plant in Haryana.
👀 What to Watch
Investors should monitor the timely completion of the Barwasni plant expansion and the execution of new export orders from Venezuela. The company's ability to maintain margins despite industry headwinds makes it a strong candidate for long-term agrochemical portfolios.
IGCL Q3 Revenue Up 10% to ₹1,085M; Top Management Re-appointed for 5 Years
Indogulf Cropsciences (IGCL) reported a 10.4% YoY revenue growth in Q3 FY26, reaching ₹1,085.81 million. Net profit for the quarter improved to ₹54.88 million from ₹45.76 million in the same period last year. The board has approved the re-appointment of the Executive Chairman and Managing Director for five-year terms, ensuring leadership stability. For the nine-month period, revenue grew to ₹5,400.09 million, reflecting a healthy upward trajectory compared to the previous year.
Key Highlights
Revenue from operations grew 10.4% YoY to ₹1,085.81 million in Q3 FY26.
Net profit for Q3 FY26 increased to ₹54.88 million compared to ₹45.76 million in Q3 FY25.
9M FY26 revenue stands at ₹5,400.09 million, up from ₹4,694.57 million YoY.
Executive Chairman and Managing Director re-appointed for 5-year terms effective April 2026.
Internal Auditor M/s Aditi Gupta & Associates appointed for FY 2025-26.
👀 What to Watch
Investors should take confidence in the management continuity and steady year-on-year growth. Monitor the company's ability to sustain margins amid fluctuating raw material costs in the agro-chemical sector.
IGCL Q3 PAT Rises 28% YoY to ₹54.9 Million; Re-appoints Top Management for 5 Years
Indogulf Cropsciences Limited (IGCL) reported a steady performance for Q3 FY26, with revenue from operations growing 10.4% YoY to ₹1,085.81 million. Net profit for the quarter saw a robust increase of 27.8% YoY, reaching ₹54.89 million, although EPS remained relatively flat due to an expanded equity base. For the nine-month period ended December 31, 2025, the company achieved a PAT of ₹414.94 million, up from ₹336.44 million in the previous year. The board also ensured leadership continuity by re-appointing the Executive Chairman and Managing Director for five-year terms starting April 2026.
Key Highlights
Revenue from operations increased 10.4% YoY to ₹1,085.81 million in Q3 FY26.
Net Profit (PAT) grew by 27.8% YoY to ₹54.89 million for the quarter.
9M FY26 Revenue reached ₹5,400.09 million compared to ₹4,694.57 million in 9M FY25.
Re-appointed Om Prakash Aggarwal as Executive Chairman and Sanjay Aggarwal as MD for 5-year terms.
Paid-up equity share capital stood at ₹632.24 million, up from ₹487.87 million in the year-ago period.
👀 What to Watch
Investors should view the double-digit profit growth and management continuity as positive signs for long-term stability. The stock's performance may be influenced by the company's ability to maintain margins in the competitive agro-chemical segment.
IGCL Appoints Deepak Tuli as VP-Accounts; Surinder Kumar Resigns as VP-Sales & Marketing
Indogulf Cropsciences Limited (IGCL) has announced key changes to its Senior Management Personnel (SMP) effective December 13, 2025. The company has appointed Mr. Deepak Tuli, a Fellow Chartered Accountant with over 26 years of experience, as the Vice President of Accounts to lead financial strategy and auditing. Concurrently, Mr. Surinder Kumar has resigned from his role as Vice President of Sales & Marketing (North & South zones) due to health challenges. These leadership shifts reflect a strengthening of the finance function while managing a transition in regional sales leadership.
Key Highlights
Appointment of Mr. Deepak Tuli as Vice President - Accounts and Senior Management Personnel effective December 13, 2025.
Mr. Deepak Tuli brings over 26 years of experience in financial strategy, taxation, and treasury across the manufacturing sector.
Resignation of Mr. Surinder Kumar from the position of Vice President - Sales & Marketing (North & South zones) effective close of business hours on December 13, 2025.
Mr. Kumar's resignation was attributed to ongoing health challenges, as per his formal resignation letter.
The Board of Directors approved these changes in a meeting held on December 13, 2025, which concluded at 3:00 P.M.
👀 What to Watch
Investors should monitor the transition in the Sales & Marketing department to ensure regional performance in the North and South zones remains stable. The appointment of a highly experienced finance professional is a positive sign for the company's internal controls and financial reporting.
